Acuitive Technologies, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2023 | $13 M | No. 3 | $10 to $50 million | equity, options | SEC | |
| Jul 2022 | $6 M | No. 2 | $2 to $10 million | equity, debt, options | SEC | |
| May 2021 | $4 M | No. 1 | $2 to $10 million | equity, debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Acuitive Technologies, Inc. reported revenue of $2.76 million for its fiscal year to 31 December 2025 (filed Apr 2026), down from $5.28 million the year before.
SEC Form C-AR · Apr 2026
The direct cost of what it sold was $2.07 million, so 25% of its revenue was left after those costs.
SEC Form C-AR · Apr 2026
Net loss for the same year: $6.43 million.
SEC Form C-AR · Apr 2026
Acuitive Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2023).
SEC Form D · Dec 2023
The industry group it chose in its notices: Other Health Care.
SEC Form D · Dec 2023
In its own words
How the company describes itself to search engines on its website, word for word.
“Acuitive Technologies Inc. is a medical device manufacturer located in Allendale, NJ committed to advancing the art and science of orthopedic surgery by developing material science technologies and unique device designs that more effectively address the clinical problems facing current state of the art orthopedic devices.”
Source: The company's website · as of Nov 15, 2026
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of Acuitive Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 35 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Alex S. Khowaylo | Executive officer | Dec 2023 |
| David S. Washburn | Executive officer | Dec 2023 |
| Michael S. McCarthy | Executive officer | Dec 2023 |
| Alex Khowaylo | Executive officer | Jun 2023 |
| Michael P. McCarthy | Executive officer | Jun 2023 |
| Alex S. Khowaylo | Director | Dec 2023 |
| David S. Washburn | Director | Dec 2023 |
| Gary S. Fischetti | Director | Dec 2023 |
| James S. Maylayter | Director | Dec 2023 |
| Michael S. McCarthy | Director | Dec 2023 |
| Vincent S. Forlenza | Director | Dec 2023 |